The use of herbal extracts in the control of influenza

Journal of Medicinal Plants Research

Volumn 3, Issue 13, 2009, Pages 1189-1194

  Hudson, James B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anti inflammatory; Antiviral; Avian 'flu; Cytokines; Herbal extracts; Influenza virus; Pandemic; Polyphenols; Swine 'flu

Indexed keywords

OSELTAMIVIR; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; THEAFLAVIN; VIRUS PROTEIN; ZANAMIVIR;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CHINESE MEDICINE; CISTUS; ECHINACEA; GERANIUM; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PLANT ROOT; POMEGRANATE; REVIEW; STRAIN DIFFERENCE; TEA; VIRUS RESISTANCE; VIRUS STRAIN;

ANIMALIA; AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 75649105722     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Altamirano-Dimas M, Sharma M, Hudson JB (2009). Echinacea and anti-inflammatory cytokine responses: Results of a gene and protein array analysis. Pharm. Biol. 47: 500-508
2. Barnes J, Anderson LA, Gibbons S, Phillipson JD (2005). Echinacea species (Echinacea angustifolia (DC.) Hell. Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench: a review of their chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 57: 929-954
3. Barrett B (2003). Medicinal properties of Echinacea: A critical review. Phytomedicine 10: 66-86.
4. Baskin CR, Carole RB, Helle B-O, Terrence MT, Patrick JS, James PL, Adolfo G-S, Tolnay A-E, Randy A, John AP,Pam HO, Lauri DA, Elizabeth RR, Kaja MK, Edward AC, Mark SK, Jamie LF, Sean P, Robert EP, Carol LS, Michael GK (2009). Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. PNAS. 106: 3455-3460.
5. Boyce WM, Sandrock C, Kreuder-Johnson C, Kelly T, Cardona C (2009). Avian influenza viruses in wild birds: A moving target. Comp. Hudson 1193 Immunol. Microbiol. Infec. Dis. 32: 275-286
6. Brundage JF, Shanks GD (2008). Deaths from Bacterial Pneumonia during 1918-19 Influenza Pandemic. Emerg. Inf. Dis. 14: 1193-1196.
7. Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E (2008). On the epidemiology of influenza. Virol. J. 5:29
8. Cheng PKC, Leung TWC, Ho ECM, Leung PKC, Ng AYY, Lai MYY, Lim WWL (2009). Oseltamivir- and Amantadine-Resistant Influenza viruses A (H1N1) Emerg. Infec. Dis. 15: 966-968
9. Droebner K, Ehrhardt C, Poetter A, Ludwig S, Planz O (2007). CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antivir. Res. 76: 1-10
10. Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, Poetter A, Dreschers S, Schmolke M, Planz O, Ludwig S (2007) A polyphenolrich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antivir. Res. 76: 38-47
11. Fedson DS (2009). Confronting the next influenza pandemic with antiinflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza and other Resp. Viruses. 3: 129-142
12. Friedman M (2007). Overview of antibacterial, antitoxin, antiviral, antifungal activities of tea flavonoids and teas. Mol. Nutr. Food Res. 51: 116-134
13. Haidari M, Ali M, Casscells SW, Madjid M (2009) Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine DOI: 10.1016.j.phymed.
14. Hudson J, Vimalanathan S, Kang L, Treyvaud Amiguet V, Livesey J, Arnason JT (2005). Characterization of antiviral activities in Echinacea root preparations. Pharm. Biol. 43: 790-796
15. Imanishi N, Tuji Y, Katada Y, Maruhashi M, Konosu S, Mantani N, Terasawa K, Ochiai H (2002). Additional Inhibitory Effect of Tea Extract on the Growth of Influenza A and B Viruses in MDCK Cells. Microbiol. Immunol. 46: 491-494
16. Jefferson T, Demicheli V, Jones M, Di Pietrantonj C, Rivetti A (2006). Antivirals for influenza in healthy adults: systematic review. Lancet 367: 303-313
17. Jefferson T, Di Pietrantonj C, Debalini MJ, Rivetti A, Demicheli V (2009). Inactivated influenza vaccines: Methods, policies, and politics. J. Clin Epidem. 62: 677-686
18. Johnston SL (2002) Anti-influenza Therapies. Virus Res. 82: 147-152
19. Kalus U, Kiesewetter H, Radtke H (2009). Effect of CYSTUS052 and Green Tea on Subjective Symptoms in Patients with Infection of the Upper Respiratory Tract. Phytother. Res. DOI: 10,1002/ptr.2876
20. Korkina LG, Pastore S, De Luca C, Kostyuk VA (2008). Metabolism of Plant Polyphenols in the Skin: Beneficial Versus Deleterious Effects. Curr. Drug Metab. 9: 710-729
21. Ludwig S (2009). Targeting cell signaling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J. Antimic. Ther. 64: 1-4
22. Michaelis M, Doerr HW, Cinatl J (2009). Novel swine-origin influenza A virus in humans: another pandemic knocking at the door Med. Microbiol. Immunol. 198: 175-183
23. Murzakhmetova M, Moldakarimov S, Tancheva L, Abarova S, Serkedjieva J (2008). Antioxidant and Prooxidant Properties of a Polyphenol-rich Extract from Geranium sanguineum L. In Vitro and In Vivo. Phytother. Res. 22: 746-751
24. Neumann G, Noda T, Kawaoka Y (2009). Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939
25. Rowe CA, Nantz MP, Bukowski JF, Percival SS (2007). Specific Formulation of Camellia sinensis Prevents Cold and Flu Symptoms and Enhances gd T Cell Function: A Randomized, Double-Blind, Placebo-Controlled Study. J. Am. Coll. Nutr. 26: 445-452
26. Schoop R, Klein P, Suter A, Johnston SL, (2006). Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin. Therapeutics. 28: 174-183
27. Serkedjieva J, Hay AJ (1998). In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L. Antivir. Res. 37: 121-130
28. Serkedjieva J, Gegova G, Mladenov K (2008). Protective efficacy of an aerosol preparation, obtained from Geranium sanguineum L., in experimental influenza infection. Pharmazie 63: 160-163
29. Sharma M, Vohra S, Arnason JT, Hudson JB (2008a). Echinacea Extracts Contain Significant and Selective Activities Against Human Pathogenic Bacteria Pharm. Biol. 46: 111-116
30. Sharma M, Schoop R, Hudson JB (2008b). Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters. Phytother. Res. 23: 863-867
31. Sharma M, Anderson SA, Schoop R, Hudson JB (2009a). Induction of pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res. 83: 165-170
32. Sharma M, Schoop R, Hudson JB (2009b). The Efficacy of Echinacea in a 3-D Tissue Model of Human Airway Epithelium. Phytother. Res. DOI:10.1002/ptr.3051
33. Song J-M, Lee K-H, Seong B-L (2005). Antiviral effect of catechins in green tea on influenza virus. Antivir. Res. 68: 66-74.
34. Suzuki Y (2009). The Highly Pathogenic Avian Influenza H5N1-Initial Molecular Signals for the Next Influenza Pandemic. Chang Gung Med. J. 32: 258-263
35. Vohra S, Adams D, Hudson JB, Moore JA, Vimalanathan S, Sharma M, Burt A, Lamont E, Lacaze N, Arnason JT, Lee TDG (2009). Selection of Natural Health Products for Clinical Trials: a Preclinical Template. Can. J. Physiol. Pharmacol. 87: 371-378
36. Vimalanathan S, Arnason JT, Hudson JB (2009). Anti-inflammatory activities of Echinacea extracts do not correlate with traditional marker components. Pharm. Biol. 47: 430-435
37. Wang X, Jia W, Zhao A, Wang X (2006). Anti-influenza Agents from Plants and Traditional Chinese Medicine. Phytother. Res. 20: 335-341
38. Yamada H, Takuma N, Daimon T, Hara Y (2006). Gargling with Tea Catechin Extracts for the Prevention of Influenza Infection in Elderly Nursing Home Residents: A Prospective Clinical Study. J. Alt. Compl. Med. 12: 669-672.